N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Proteome Research

• Publication date

  2012-04-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr201070kPMID 22304416PMCID PMC3321095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array

  2012cited by this paper
• Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer

  2012cited by this paper
• Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.

  2011cited by this paper
• Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.

  2011cited by this paper
• Novel glycan biomarkers for the detection of lung cancer.

  2011cited by this paper
• Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma.

  2011cited by this paper
• N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex.

  2010cited by this paper
• Identification of candidate biomarkers with cancer‐specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis

  2010cited by this paper
• Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.

  2010cited by this paper
• Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in‐gel electrophoresis

  2010cited by this paper
• Alterations in glycosylation as biomarkers for cancer detection

  2010cited by this paper
• Mass Spectrometry Based Glycoproteomics—From a Proteomics Perspective*

  2010cited by this paper
• Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

  2010cited by this paper
• N‐glycosylation status of β‐haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects

  2009cited by this paper
• The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Lectin Sandwich Arrays*

  2009cited by this paper
• Detection of Hepatocellular Carcinoma Using Glycomic Analysis

  2009cited by this paper
• Glycan array: a powerful tool for glycomics studies

  2009cited by this paper
• Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis

  2009cited by this paper
• Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets.

  2009cited by this paper
• A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

  2008cited by this paper
• ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics.

  2008cited by this paper
• Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray

  2008cited by this paper
• Focused glycomic analysis of the N‐linked glycan biosynthetic pathway in ovarian cancer

  2008cited by this paper
• Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum‐resistant ovarian cancer and primary peritoneal carcinomatosis

  2008cited by this paper
• Evaluation of the serum N‐linked glycome for the diagnosis of cancer and chronic inflammation

  2008cited by this paper
• ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand

  2008cited by this paper
• Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.

  2008cited by this paper
• Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects

  2008cited by this paper
• Glycoforms of CA125 antigen as a possible cancer marker

  2008cited by this paper
• Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

  2008cited by this paper
• Haptoglobin and posttranslational glycan‐modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer

  2007cited by this paper
• Alterations in the serum glycome due to metastatic prostate cancer.

  2007cited by this paper
• Early Detection of Ovarian Cancer

  2007cited by this paper
• Protein arrays for biomarker discovery.

  2007cited by this paper
• Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

  2007cited by this paper
• Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

  2007cited by this paper
• Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers

  2006cited by this paper
• Plasma proteomic pattern as biomarkers for ovarian cancer.

  2006cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• Interleukin‐1β induces sialyl Lewis X on hepatocellular carcinoma HuH‐7 cells via enhanced expression of ST3Gal IV and FUT VI gene

  2006cited by this paper
• Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.

  2006cited by this paper
• Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.

  2006cited by this paper
• Glycans in cancer and inflammation — potential for therapeutics and diagnostics

  2005cited by this paper
• Serum protein markers for early detection of ovarian cancer.

  2005cited by this paper
• New tumor markers: CA125 and beyond

  2005cited by this paper
• Solid-phase permethylation of glycans for mass spectrometric analysis.

  2005cited by this paper
• Human immunoglobulin glycosylation and the lectin pathway of complement activation.

  2005cited by this paper
• Characterization of serum biomarkers for detection of early stage ovarian cancer

  2005cited by this paper
• Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer

  2004cited by this paper
• Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

  2004cited by this paper
• The Human Plasma Proteome

  2004cited by this paper
• Changes in serum IgG oligosaccharide chains with prostate cancer progression.

  2004cited by this paper
• CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

  2004cited by this paper
• Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

  2004cited by this paper
• Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

  2004cited by this paper
• The Human Plasma Proteome

  2002cited by this paper
• Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.

  2001cited by this paper
• Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro.

  2000cited by this paper
• Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation.

  2000cited by this paper
• Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labelled lectins

  1994cited by this paper
• Biological roles of oligosaccharides: all of the theories are correct

  1993cited by this paper
• Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer.

  1992cited by this paper
• Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma.

  1989cited by this paper
• The CA 125 tumour-associated antigen: a review of the literature.

  1989cited by this paper
• Measuring the accuracy of diagnostic systems.

  1988cited by this paper
• Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.

  1987cited by this paper
• Variations of Box Plots

  1978cited by this paper
• Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles

  year unknowncited by this paper

• Electrochemical Strategies to Evaluate the Glycosylation Status of Biomolecules for Disease Diagnosis

  2026cites this paper
• IgG Gal-ratio, a promising serum biomarker for detecting ovarian cancer in as early as stage I disease.

  2026cites this paper
• The importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis

  2025cites this paper
• GlycoKnow Ovarian: a Glycoprotein-based, Serum Diagnostic to Distinguish Ovarian Cancers from Benign Pelvic Masses

  2025cites this paper
• High-Mannose N‑Glycans To Monitor Early Response to Chemotherapy in African Epithelial Ovarian Cancer PatientsA Pilot Study

  2025cites this paper
• IgG galactosylation changes in cancer.

  2025cites this paper
• MicroRNAs in circulating extracellular vesicles as biomarkers of early colorectal cancer captured using high mannose N-glycan-specific lectin from Oscillatoria Agardhii

  2025cites this paper
• Glycosylation in Cancer.

  2025cites this paper
• Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction

  2024cites this paper
• Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects

  2024cites this paper
• N-glycan profiling of tissue samples to aid breast cancer subtyping

  2024cites this paper
• Development of an impedance-based biosensor for determination of IgG galactosylation levels.

  2023cites this paper
• Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling

  2023cites this paper
• Highly-sensitive label-free deep profiling of N-glycans released from biomedically-relevant samples

  2023cites this paper
• Advancements in protein glycosylation biomarkers for ovarian cancer through mass spectrometry-based approaches

  2023cites this paper
• Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers

  2023cites this paper
• Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.

  2023cites this paper
• NOVEL PLASMA GLYCOPROTEIN BIOMARKERS PREDICT PROGRESSION-FREE SURVIVAL IN SURGICALLY RESECTED CLEAR CELL RENAL CELL CARCINOMA

  2022cites this paper
• Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity

  2022cites this paper
• MS-based glycomics: An analytical tool to assess nervous system diseases

  2022cites this paper
• Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers

  2022cites this paper
• Immunoglobulin G glycans - biomarkers and molecular effectors of aging.

  2022cites this paper
• Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model.

  2022cites this paper
• Fractionation and Characterization of Sialyl Linkage Isomers of Serum N-Glycans by CE-MS.

  2022cites this paper
• Glycosylation and its research progress in endometrial cancer

  2022cites this paper
• Differentiation of Sialyl Linkages Using a Combination of Alkyl Esterification and Phenylhydrazine Derivatization: Application for N-Glycan Profiling in the Sera of Patients with Lung Cancer.

  2022cites this paper
• Isomer-specific biomarker discovery in multiple myeloma with dual-derivatized N-glycans

  2022cites this paper
• Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers

  2022cites this paper
• The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers

  2021cites this paper
• IgG N-glycans.

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• High-Sensitivity Glycan Profiling of Blood-Derived Immunoglobulin G, Plasma, and Extracellular Vesicle Isolates with Capillary Zone Electrophoresis-Mass Spectrometry.

  2021cites this paper
• Specific Analysis of α-2,3-Sialylated N-Glycan Linkage Isomers by Microchip Capillary Electrophoresis-Mass Spectrometry.

  2021cites this paper
• Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges

  2021influential citation
• Rhizoctonia bataticola lectin induces apoptosis and inhibits metastasis in ovarian cancer cells by interacting with CA 125 antigen differentially expressed on ovarian cells

  2021cites this paper
• Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment

  2021cites this paper
• ИСПОЛЬЗОВАНИЯ СИАЛИРОВАННЫХ ИММУНОГЛОБУЛИНОВ В ТЕРАПИИ РАЗЛИЧНЫХ ЗАБОЛЕВАНИЙ PROSPECTS FOR THE USE OF SIALYLATED IMMUNOGLOBULINS IN DISEASE TREATMENT

  2020cites this paper
• Mass Spectrometry Methods for In Situ Analysis of Clinical Biomolecules

  2020cites this paper
• Prospects for the use of sialylated immunoglobulins in the treatment of different diseases

  2020cites this paper
• Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy

  2020cites this paper
• Investigation of acidic free-glycans in urine and their alteration in cancer

  2020cites this paper
• Перспективы использования сиалированных иммуноглобулинов в терапии различных заболеваний

  2020cites this paper
• Analysis of the correlation between alterations in N‑glycans and invasiveness in liver cancer cell lines.

  2020cites this paper
• Glycoproteomic Analysis of Human Urinary Exosomes.

  2020cites this paper
• Fmoc N-hydroxysuccinimide ester: A facile and multifunctional role in N-glycan analysis.

  2020cites this paper
• N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer.

  2020cites this paper
• A robust glycan labeling strategy using a new cationic hydrazide tag for MALDI-MS-based rapid and sensitive glycomics analysis.

  2020cites this paper
• Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases

  2020cites this paper
• Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer

  2020cites this paper
• Dynamic analysis of N-glycomic and transcriptomic changes in the development of ovarian cancer cell line A2780 to its three cisplatin-resistant variants

  2020cites this paper
• Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.

  2020cites this paper
• A method for detecting tumor cells derived from colorectal cancer by targeting cell surface glycosylation with affinity capillary electrophoresis.

  2020cites this paper
• Comprehensive analysis of human IgG Fc N-glycopeptides and construction of a screening model for colorectal cancer.

  2019cites this paper
• Highly Sensitive O-Glycan Profiling for Human Serum Proteins Reveals Gender-Dependent Changes in Colorectal Cancer Patients.

  2019cites this paper
• Quantitative proteomic analyses in blood: A window to human health and disease

  2019cites this paper
• Increased expression of core-fucosylated glycans in human lung squamous cell carcinoma

  2019cites this paper
• Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer

  2019cites this paper
• Sialic Acid Linkage Analysis Refines the Diagnosis of Ovarian Cancer

  2019cites this paper
• ST3Gal3 confers paclitaxel-mediated chemoresistance in ovarian cancer cells by attenuating caspase-8/3 signaling

  2019cites this paper
• Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future.

  2019cites this paper
• ABERRANT N-GLYCOSYLATION REGULATES INVASION OF MG-63 CELLS THROUGH EXTRACELLULAR MATRIX REMODELING

  2019cites this paper
• Core fucosylation of copper transporter 1 plays a crucial role in cisplatin‐resistance of epithelial ovarian cancer by regulating drug uptake

  2019cites this paper
• Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery.

  2019cites this paper
• In-Depth Compositional and Structural Characterization of N-Glycans Derived from Human Urinary Exosomes.

  2019cites this paper
• A gas chromatography-mass spectrometry (GC-MS) metabolomic approach in human colorectal cancer (CRC): the emerging role of monosaccharides and amino acids.

  2019cites this paper
• Profiling of isomer-specific IgG N-glycosylation in cohort of Chinese colorectal cancer patients.

  2019cites this paper
• Plasma N-glycans in colorectal cancer risk

  2018cites this paper
• Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses.

  2018cites this paper
• Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.

  2018cites this paper
• Differential N-glycan patterns identified in lung adenocarcinoma by N-glycan profiling of formalin-fixed paraffin-embedded (FFPE) tissue sections.

  2018cites this paper
• Analytical Scheme Leading to Integrated High-Sensitivity Profiling of Glycosphingolipids Together with N- and O-Glycans from One Sample

  2018cites this paper
• Identification of internally sialylated carbohydrate tumor marker candidates, including Sda/CAD antigens, by focused glycomic analyses utilizing the substrate specificity of neuraminidase

  2018cites this paper
• Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases

  2018cites this paper
• Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

  2018cites this paper
• Immunoglobulin G glycosylation in aging and diseases.

  2018cites this paper
• Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

  2018cites this paper
• Glycoproteomic Alterations in Drug-Resistant Nonsmall Cell Lung Cancer Cells Revealed by Lectin Magnetic Nanoprobe-Based Mass Spectrometry.

  2018cites this paper
• Clinical application of quantitative glycomics

  2018cites this paper
• Profiling the N-Glycan Composition of IgG with Lectins and Capillary Nanogel Electrophoresis

  2018cites this paper
• Mass spectrometry for glycan biomarker discovery

  2018cites this paper
• N-Glycosylation profiles as a risk stratification biomarker for Type II Diabetes Mellitus and its associated factors

  2018cites this paper
• The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.

  2017cites this paper
• Characterization of isomeric glycan structures by LC‐MS/MS

  2017cites this paper
• Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome

  2017cites this paper
• Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis

  2017cites this paper
• Serum-based N-glycan biomarker for diagnosis of epithelial ovarian cancer. The ascites N-glycome of epithelial ovarian cancer.

  2017cites this paper
• Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma

  2017cites this paper
• Comprehensive Analytical Approach toward Glycomic Characterization and Profiling in Urinary Exosomes.

  2017cites this paper
• Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach.

  2017cites this paper
• Recent Advances in the Analysis of Complex Glycoproteins.

  2017cites this paper
• The ascites N-glycome of epithelial ovarian cancer patients.

  2017cites this paper
• Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer

  2017cites this paper
• Glycosylation patterns of selected proteins in individual serum and cerebrospinal fluid samples

  2017cites this paper
• Serum N‐glycans outperform CA19‐9 in diagnosis of extrahepatic cholangiocarcinoma

  2017cites this paper
• Capillary electrophoresis-mass spectrometry for direct structural identification of serum N-glycans.

  2017cites this paper
• Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method

  2017cites this paper
• Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp

  2017cites this paper
• Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients

  2017cites this paper
• One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.

  2017cites this paper
• Elevation of CA19-9-Related Novel Marker, Core 1 Sialyl Lewis A, in Sera of Adenocarcinoma Patients Verified by a SRM-Based Method.

  2016cites this paper